NASDAQ : PAHC

Phibro Animal Health Corporation

$36.7515 USD

-$0.4 (-1.07%)

Volume
86.61K
Average Volume
355.64K
Market Capitalization
$1.49B
P/E Ratio
15.71
Dividend Yield
1.31%
Price Target
$49.00
Year High
$60.08
Year Low
$26.08
Day High
—
Day Low
—
Payout Ratio
$0.20
Current Ratio
$3.17
Company Overview

NASDAQ

Daniel Bendheim

Drug Manufacturers - Specialty & Generic

Healthcare

PAHC

2475

US

USD

https://www.pahc.com

201 329 7300

71742Q106

0001069899

Liquidity Metrics

2.18

3.17

1.26

0.19

0.20

Sales & Valuation

$1.3B

0.99

4.12

116.66

0.31

Profitability

$1.19

$48.26M

6.35%

8.59%

29.49%

6.59%

P/E Metrics

15.71

0.08

0.08

Analyst Price Target & Rating

$49.00

$49.00

$49.00

Neutral

3/5

14 Analysts

-25.00%

Financial Health Scores

3.09

6/9

$612.2M

$1.45B

$1.08B

$174.73M

Key Metrics (TTM)

$2.24B

1.49

9.94

3.17

29.49%

11.38%

6.32%

0.85%

$21.71

202 days

Company Executives
Name Title
Daniel Bendheim CEO, President & Director
Jack Clifford Bendheim Executive Chairman
Michael Giambalvo President of PhibroChem and Ethanol Performance Group
Todd Armstrong President of North American Region
Judith A. Weinstein Senior Vice President, General Counsel & Corporate Secretary
Lisa A. Escudero Senior Vice President of Human Resources
Anthony J. Andolino Vice President of Finance & Treasurer
Mona Desai Vice President & Corporate Controller
Glenn C. David Chief Financial Officer
Larry L. Miller Chief Operating Officer
Jonathan Bendheim Executive Vice President of Global Technology & People and Director
Ramon Fuenmayor President South America Region
Samson Li President of Asia Pacific Region
Poll Results

No votes yet today — be the first to share your view!

About Phibro Animal Health Corporation (NASDAQ:PAHC) Stock

Phibro Animal Health Corporation operates as a global entity focused on the research, production, and supply of a wide array of animal health and mineral nutrition solutions. While serving a global clientele, its primary market for livestock products is the United States. The company's operations are divided into three main business segments: Animal Health, Mineral Nutrition, and Performance Products. Phibro develops, manufactures, and markets products tailored for various food-producing animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its Animal Health offerings encompass a broad range of pharmaceutical and biological products. These include antimicrobials (both chemical and biological agents) designed to prevent and treat bacterial ailments; anticoccidials, prim ... arily used to control and prevent coccidiosis in poultry and cattle; anthelmintics for combating parasitic intestinal worm infestations; and specific anti-bloat treatments for cattle grazing on legume or wheat pastures. Additionally, the company provides specialized nutritional supplements engineered to enhance animal health and performance, alongside vaccines predominantly for the poultry and swine industries to protect against diseases. The Mineral Nutrition segment focuses on the creation and distribution of various trace mineral formulations and concentrates, featuring elements such as zinc, manganese, copper, iron, and other vital compounds. Furthermore, under its Performance Products segment, Phibro supplies an assortment of specialty ingredients that find application in diverse industries, including personal care, industrial chemicals, and chemical catalysts. Phibro's animal health and mineral nutrition products reach customers through a multi-channel distribution network, including its own local sales offices, direct sales to integrated poultry, swine, and cattle operations, and through commercial animal feed producers, wholesalers, and distributors. The company boasts an extensive international presence, conducting business across the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific region. Initially known as Philipp Brothers Chemicals, Inc., the company adopted the name Phibro Animal Health Corporation in July 2003. It was officially incorporated in 2014 and maintains its corporate headquarters in Teaneck, New Jersey.

Phibro Animal Health Corporation Declares Quarterly Dividend

2026-07-28 16:10:00

TEANECK, N.J.--(BUSINESS WIRE)--The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, , payable on September 23, 2026, to stockholders of record at the close of business on September 2, 2026.About Phibro Animal Health CorporationPhibro Animal Health Corporation is a leading global diversified animal health and nutrition company. We strive to be a trusted partner w.

PAHC vs. SYK: Which Stock Is the Better Value Option?

2026-07-27 12:43:13

Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Stryker (SYK). But which of these two companies is the best option for those looking for undervalued stocks?

Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term

2026-07-14 10:40:18

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

PAHC or LZAGY: Which Is the Better Value Stock Right Now?

2026-07-09 12:40:49

Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Lonza Group Ag (LZAGY). But which of these two stocks is more attractive to value investors?

Implied Volatility Surging for Phibro Animal Health Stock Options

2026-07-06 11:11:10

Investors need to pay close attention to PAHC stock based on the movements in the options market lately.

Wall Street Analysts Predict a 36.23% Upside in Phibro (PAHC): Here's What You Should Know

2026-06-29 10:55:52

The average of price targets set by Wall Street analysts indicates a potential upside of 36.2% in Phibro (PAHC). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

PAHC vs. SYK: Which Stock Is the Better Value Option?

2026-06-22 12:41:10

Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Stryker (SYK). But which of these two companies is the best option for those looking for undervalued stocks?

What Makes Phibro (PAHC) a New Buy Stock

2026-06-17 13:01:19

Phibro (PAHC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Frequently Asked Questions

What is the current Phibro Animal Health Corporation (PAHC) stock price?

Phibro Animal Health Corporation(NASDAQ:PAHC) stock price is $36.7515 in the last trading session. During the trading session, PAHC stock reached the peak price of $60.08 while $26.082 was the lowest point it dropped to. The percentage change in PAHC stock occurred in the recent session was --1.07% while the dollar amount for the price change in PAHC stock was -$0.4.

PAHC's industry and sector of operation?

The NASDAQ listed PAHC is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.

Who are the executives of PAHC?

Daniel Bendheim | CEO, President & Director
Jack Clifford Bendheim | Executive Chairman
Michael Giambalvo | President of PhibroChem and Ethanol Performance Group
Todd Armstrong | President of North American Region
Judith A. Weinstein | Senior Vice President, General Counsel & Corporate Secretary

How many employees does PAHC have?

Number of PAHC employees currently stands at 2475. PAHC operates from Glenpointe Centre East, Teaneck, NJ 07666-6712, US.

Link for PAHC official website?

Official Website of PAHC is: https://www.pahc.com

How do I contact PAHC?

PAHC could be contacted at phone #201 329 7300 and can also be accessed through its website. PAHC operates from Glenpointe Centre East, Teaneck, NJ 07666-6712, US.

How many shares of PAHC are traded daily?

The average number of PAHC shares traded daily for last 3 months was 355.64K.

What is the market cap of PAHC currently?

The market value of PAHC currently stands at $1.49B with its latest stock price at $36.7515